Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023

Stock Information for Augmedix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Augmedix Inc.

Augmedix Awarded on Newsweek's World's Best Digital Health Companies 2024 List
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
Augmedix to Participate in Citizens JMP Technology Conference
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Augmedix, Inc. (NASDAQ: AUGX)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.